Literature DB >> 28339360

Critical role of STIR MRI in early detection of post-streptococcal periostitis with dysproteinaemia (Goldbloom's syndrome).

Riccardo Papa1, Alessandro Consolaro2, Francesca Minoia2, Roberta Caorsi2, Gianmichele Magnano3, Marco Gattorno2, Angelo Ravelli4, Paolo Picco2.   

Abstract

OBJECTIVES: In 1966, Goldbloom et al. described two children who developed a peculiar clinical picture characterized by intermittent daily bone pain in the lower limbs, fever spikes, increased acute phase reactants and dysproteinaemia. The syndrome occurred two weeks after a group A β-haemolytic streptococcus infection. So far, only a few cases have been reported in the medical literature in English.
METHODS: We report two further cases of Goldbloom's syndrome with a review of the literature in English.
RESULTS: Our two patients lived in the same Italian region and presented their syndrome onset a week apart. Early use of STIR MRI revealed an atypical metaphyseal hyperintensity in the femurs and tibias. X-ray showed periosteal hyperostosis. A short cycle of corticosteroids led to rapid recovery of symptoms and disappearance of bone changes.
CONCLUSIONS: The reported cases highlight a likely under-recognised post-streptococcal inflammatory periosteal reaction and emphasise the diagnostic utility of the newer imaging modalities.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28339360

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

Review 1.  Radiographic overlap of recurrent Caffey disease and chronic recurrent multifocal osteomyelitis (CRMO) with considerations of molecular origins.

Authors:  Teresa Chapman; Sarah J Menashe; Benjamin H Taragin
Journal:  Pediatr Radiol       Date:  2019-12-23

Review 2.  Osteoperiostitis in children: proposal for a diagnostic algorithm.

Authors:  Francesco Zulian; Elena Marigo; Francesca Ardenti-Morini; Fabio Vittadello; Monica Zuliani; Chiara Giraudo; Alessandra Meneghel; Giorgia Martini
Journal:  Eur J Pediatr       Date:  2021-04-08       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.